Marcello Dallio - Concepedia

Author

Marcello Dallio

University of Campania "Luigi Vanvitelli"ORCID

Also Known As

Francesco Selvaggi, M Dallio, M. Dallio, MARCELLO DALLIO, Marcello DALLIO, Marcello Dallio, Umberto Vespasiani-Gentilucci

181

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

University of Campania "Luigi Vanvitelli"University of Naples Federico II University of Salerno Agostino Gemelli University Polyclinic University of Turin

About

Marcello Dallio is an author at University of Campania "Luigi Vanvitelli" specializing in medicine, hepatology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	905
2	Public Health	3	3	106
3	Health Sciences	2	2	131
4	Biostatistics	1	1	31
5	Diabetes	1	1	55

Marcello Dallio

Publications

Citations

H-Index

Page 1

	Year	Citations
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial Paolo Caraceni, Oliviero Riggio, Paolo Angeli, The Lancet HepatologyDecompensated CirrhosisLiver PhysiologyGastroenterologyAcute Liver Failure	2018	499
Postoperative Changes in Fecal Bacterial Communities and Fermentation Products in Obese Patients Undergoing Bilio-Intestinal Bypass Vania Patrone, Elia Vajana, Andrea Minuti, Frontiers in Microbiology	2016	114
Rare ATG7 genetic variants predispose patients to severe fatty liver disease Guido Baselli, Oveis Jamialahmadi, Serena Pelusi, Journal of Hepatology	2022	85
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery. Alessandro Federico, Marcello Dallio, Salvatore Tolone, PubMed	2017	79
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis Mario Masarone, Jacopo Troisi, Andrea Aglitti, Metabolomics Metabolic SyndromeMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver Disease	2021	76
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites Paolo Caraceni, Manuel Tufoni, Giacomo Zaccherini, Journal of Hepatology UrologyHepatologyUncomplicated AscitesLiver PhysiologyLong-term Treatment	2020	67
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients Alessandro Federico, Marcello Dallio, Mario Masarone, Oxidative Medicine and Cellular Longevity	2019	66
Recovery of <i>Bacteroides thetaiotaomicron</i> ameliorates hepatic steatosis in experimental alcohol-related liver disease Moris Sangineto, Christoph Grander, Felix Grabherr, Gut Microbes	2022	66
Gut microbiota correlates with antitumor activity in patients with <scp>mCRC</scp> and <scp>NSCLC</scp> treated with cetuximab plus avelumab Giulia Martini, Davide Ciardiello, Marcello Dallio, International Journal of Cancer DysbiosisAntitumor ActivityImmunologyPathologyGut Microbiota	2022	61
Role of bisphenol A as environmental factor in the promotion of non‐alcoholic fatty liver disease: in vitro and clinical study Marcello Dallio, Mario Masarone, Simona Errico, Alimentary Pharmacology & Therapeutics	2018	57

Page 1